Completed PHASE2 INTERVENTIONAL 2-arm NCT01949324

A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel

A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

Sponsor: Neurotech Pharmaceuticals

Conditions Macular Telangiectasia Type 2

Interventions Ciliary neurotrophic factor (CNTF) NT-501 Implant NT-501 Implant procedure Sham procedure

Updated 12 times since 2017 Last updated: Sep 10, 2018 Started: Apr 30, 2014 Primary completion: Apr 14, 2017 Completion: May 22, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01949324, this PHASE2 trial focuses on Macular Telangiectasia Type 2 and remains completed. Sponsored by Neurotech Pharmaceuticals, it has been updated 12 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Feb 2020 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 7 earlier versions

Jun 2019 — Feb 2020 [monthly]

Completed PHASE2
Oct 2018 — Jun 2019 [monthly]

Completed PHASE2
Sep 2018 — Oct 2018 [monthly]

Completed PHASE2
Jun 2018 — Sep 2018 [monthly]

Completed PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Feb 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neurotech Pharmaceuticals
The Emmes Company, LLC
The Lowy Medical Research Institute Limited

Data source: Neurotech Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Atlanta, United States , Beachwood, United States , Bethesda, United States , Boston, United States , East Melbourne, Australia , Los Angeles, United States , Madison, United States , Miami, United States , Nedlands, Australia and 1 more location